Literature DB >> 11973611

Accumulation of an inactive form of p53 protein in cells treated with TNF alpha.

P Drané1, V Leblanc, F Miro-Mur, R Saffroy, B Debuire, E May.   

Abstract

In MCF-7 cells, TNF alpha induces a G1 arrest with an increased expression of p21/Waf1, an activation of NF-kappa B and an accumulation of p53. NF-kappa B and p53 are two transcriptional factors known to activate p21/Waf1 gene expression. Here we show that p53 inhibition has no effect on p21/Waf1 mRNA accumulation following TNF alpha treatment. In contrast, inactivation of NF-kappa B inhibits p21/Waf1 expression without affecting G1 arrest. The fact that p21/Waf1 gene expression is still stimulated when p53 is inactivated strongly suggests that TNF alpha induces accumulation of an inactive form of p53 protein. This assumption was further supported by the following observations: (i) the p53 DNA-binding activity to its consensus sequence was not stimulated following TNF alpha treatment, (ii) phosphorylation at Ser-15, -20 or -392 was not detected in response to TNF alpha, (iii) the transcription rate of Ddb2, another p53 target gene, was not stimulated by TNF alpha. Finally, the accumulation of p53 in the nuclei of TNF alpha-treated MCF-7 cells was concomitant with an increase in p53 mRNA level, suggesting a regulation at the transcription level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973611     DOI: 10.1038/sj.cdd.4400983

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  6 in total

1.  Use of pifithrin to inhibit p53-mediated signalling of TNF in dystrophic muscles of mdx mice.

Authors:  Felicity J Waters; Thea Shavlakadze; Matthew J McIldowie; Matthew J Piggott; Miranda D Grounds
Journal:  Mol Cell Biochem       Date:  2009-10-27       Impact factor: 3.396

2.  Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function.

Authors:  Jane Muret; Meriem Hasmim; Izabela Stasik; Abdelali Jalil; Aude Mallavialle; Arash Nanbakhsh; Ludovic Lacroix; Katy Billot; Véronique Baud; Jérome Thiery; Philippe Vielh; Philippe Terrier; Joelle Wiels; Lyubomir Vassilev; Axel Lecesne; Sylvie Bonvalot; Salem Chouaib
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

3.  Expression of C-terminal deleted p53 isoforms in neuroblastoma.

Authors:  David Goldschneider; Emilie Horvilleur; Louis-François Plassa; Marine Guillaud-Bataille; Karine Million; Evelyne Wittmer-Dupret; Gisèle Danglot; Hughes de Thé; Jean Bénard; Evelyne May; Sétha Douc-Rasy
Journal:  Nucleic Acids Res       Date:  2006-10-05       Impact factor: 16.971

4.  Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.

Authors:  Theophilos Tzaridis; Till Milde; Kristian W Pajtler; Sebastian Bender; David T W Jones; Simone Müller; Andrea Wittmann; Magdalena Schlotter; Andreas E Kulozik; Peter Lichter; V Peter Collins; Olaf Witt; Marcel Kool; Andrey Korshunov; Stefan M Pfister; Hendrik Witt
Journal:  Oncotarget       Date:  2016-09-20

5.  Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells.

Authors:  Pabbisetty Sudheer Kumar; Anjali Shiras; Gowry Das; Jayashree C Jagtap; Vandna Prasad; Padma Shastry
Journal:  Mol Cancer       Date:  2007-06-12       Impact factor: 27.401

6.  High Glucose Exacerbates TNF-α-Induced Proliferative Inhibition in Human Periodontal Ligament Stem Cells through Upregulation and Activation of TNF Receptor 1.

Authors:  Wenjun Zhu; Qihong Qiu; Haoyuan Luo; Fuping Zhang; Juan Wu; Xiaorui Zhu; Min Liang
Journal:  Stem Cells Int       Date:  2020-02-05       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.